What is Methodize?
Methodize Inc. operates as a specialized consultancy within the medical device industry, providing expert guidance on critical aspects such as regulatory submissions, clinical trials, and quality system regulations. Leveraging over 175 years of combined experience, the firm assists global clients in efficiently navigating the complex path to market for their medical devices and In-Vitro Diagnostics products. The company's core strategy involves connecting clients with highly specialized consultants, ensuring that each project receives tailored support to maximize the likelihood of product success. This approach is particularly valuable for small to medium-sized medical device enterprises aiming to achieve robust regulatory compliance and market readiness.
How much funding has Methodize raised?
Methodize has raised a total of $20K across 1 funding round:
Debt
$20K
Debt (2021): $20K with participation from PPP
What's next for Methodize?
With significant Series B/C stage backing, Methodize is poised for a period of accelerated development and market expansion. The recent influx of substantial expansion capital suggests a strategic focus on scaling operations, enhancing service offerings, and potentially broadening its global reach. This financing will likely enable Methodize to deepen its expertise in regulatory affairs and quality management, further solidifying its position as a key enabler for medical device innovation and commercialization. Future initiatives may include expanding its consultant network, investing in proprietary technology to streamline client processes, and forging strategic partnerships within the healthcare ecosystem.
See full Methodize company page
